missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DGCR8 (aa 70-250) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a subunit of the microprocessor complex which mediates the biogenesis of microRNAs from the primary microRNA transcript. The encoded protein is a double-stranded RNA binding protein that functions as the non-catalytic subunit of the microprocessor complex. This protein is required for binding the double-stranded RNA substrate and facilitates cleavage of the RNA by the ribonuclease III protein, Drosha. Alternate splicing results in multiple transcript variants.
Specifications
Specifications
| Accession Number | Q8WYQ5 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 54487 |
| Name | Human DGCR8 (aa 70-250) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | C22orf12; D16H22S1742E; D16H22S788E; D16Wis2; DGCR8; DGCR8 microprocessor complex subunit; DGCR8, microprocessor complex subunit; DGCRK6; DiGeorge syndrome critical region 8; diGeorge syndrome critical region 8 homolog; DiGeorge syndrome critical region gene 8; Gy1; LP4941; Microprocessor complex subunit DGCR8; mir-1306; N41; pasha; sb:eu827; sb:eu832; si:ch211-106a19.4; Vo59c07; wu:fc23f08; wu:fc38f06 |
| Common Name | DGCR8 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction